Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01970462 · ClinicalTrials.gov registry record · Phase 4
Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery
A Phase 4 study, sponsored by Kathleen Dungan.
- Terminated
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT01970462: Clinical Trial Phase 4 study, sponsored by Kathleen Dungan.
NCT01970462 is a Phase 4 study that was terminated before completion, run by Kathleen Dungan. The registered enrollment target is 8 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01970462, a Phase 4 study, was terminated before completion, sponsored by Kathleen Dungan.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to determine the safety and efficacy of Sitagliptin in patients with stress hyperglycemia or mild diabetes following cardiac surgery. Patients will receive Sitagliptin or placebo. Sitagliptin may be of particular use in this patient population due to the effects on hepatic glucose production (a major feature of SH), safety (lack of contra-indications for heart failure or renal failure and no hypoglycemia), and tolerability. The secondary objective of this study is to determine whether the management of patients with persistent insulin requirements following cardiac surgery differs among patients with stress hyperglycemia or mild diabetes.
Primary Outcome
Difference in mean fasting glucose at 6 weeks post-discharge.
Interventions
- DRUG Placebo
- DRUG Sitagliptin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-01 |
| Est. Completion | 2016-08 |
| Phase | Phase 4 |
Why NCT01970462 stopped before completion
NCT01970462 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01970462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01970462 about?
NCT01970462 is a clinical study titled "Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery". This is a randomized controlled trial to determine the safety and efficacy of Sitagliptin in patients with stress hyperglycemia or mild diabetes following cardiac surgery. Patients will receive Sitagliptin or placebo. Sitagliptin may be of particular use in this patient population due to the effects...
What is the current status of trial NCT01970462?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2014-01. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01970462?
The interventions under investigation include: Placebo (DRUG), Sitagliptin (DRUG).
Who is sponsoring clinical trial NCT01970462?
This trial is sponsored by Kathleen Dungan, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01970462's enrollment target sits among peer trials
8 1972nd of 2000 higher than 20 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia